HEM Pharma Inc. (KOSDAQ:376270)
South Korea · Delayed Price · Currency is KRW 61,700
+2,200 (3.70%)
At close: Apr 29, 2026
HEM Pharma Market Cap
HEM Pharma has a market cap or net worth of 429.14 billion as of April 30, 2026. Its market cap has increased by 163.98% in one year.
Market Cap
429.14B
Enterprise Value
434.83B
Revenue
12.98B
Ranking
n/a
PE Ratio
n/a
Stock Price
61,700.00
Market Cap Chart
Since November 5, 2024, HEM Pharma's market cap has increased from 114.18B to 429.14B, an increase of 275.85%. That is a compound annual growth rate of 144.31%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 30, 2026 | 429.14B | 31.04% |
| Dec 30, 2025 | 327.49B | 185.09% |
| Dec 30, 2024 | 114.87B | 0.61% |
| Nov 5, 2024 | 114.18B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Myung In Pharmaceutical LTD. | 826.36B |
| Samyang Biopharm | 579.25B |
| ImmuneOncia Therapeutics | 527.98B |
| CellBion | 478.62B |
| DAE HWA Pharmaceutical | 262.05B |
| NOVAREX | 261.47B |
| GREEN CROSS WellBeing | 241.87B |
| High Tech Pharm | 207.03B |